Second, enzyme inhibitors and receptor antagonists have
been developed to interfere with the synthesis or effects
of the eicosanoids.
The discovery of (blank)as a major source of inflammatory
prostanoids led to the development of selective COX-2
inhibitors to preserve the gastrointestinal and
renal functions directed through COX-1, thereby reducing toxicity
COX-2